Stanislav Kormunda

709 total citations
30 papers, 550 citations indexed

About

Stanislav Kormunda is a scholar working on Oncology, Epidemiology and Molecular Biology. According to data from OpenAlex, Stanislav Kormunda has authored 30 papers receiving a total of 550 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 7 papers in Epidemiology and 6 papers in Molecular Biology. Recurrent topics in Stanislav Kormunda's work include Colorectal Cancer Treatments and Studies (9 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers) and Renal Transplantation Outcomes and Treatments (5 papers). Stanislav Kormunda is often cited by papers focused on Colorectal Cancer Treatments and Studies (9 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers) and Renal Transplantation Outcomes and Treatments (5 papers). Stanislav Kormunda collaborates with scholars based in Czechia. Stanislav Kormunda's co-authors include Vladislav Třeška, Tomáš Reischig, Pavel Jindra, Ondřej Topolčan, L Holubec, Jindřich Fínek, Mirko Bouda, Ondřej Hes, Zdeněk Kleibl and Petra Kleiblová and has published in prestigious journals such as Journal of the American Society of Nephrology, International Journal of Environmental Research and Public Health and Transplantation.

In The Last Decade

Stanislav Kormunda

30 papers receiving 548 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stanislav Kormunda Czechia 13 294 185 105 96 81 30 550
Roni Tamari United States 18 278 0.9× 176 1.0× 161 1.5× 33 0.3× 135 1.7× 98 977
Ken Ishiyama Japan 17 186 0.6× 141 0.8× 77 0.7× 24 0.3× 76 0.9× 100 865
Masatoshi Sakurai Japan 13 118 0.4× 93 0.5× 105 1.0× 24 0.3× 61 0.8× 69 497
Maija Itälä‐Remes Finland 17 239 0.8× 77 0.4× 126 1.2× 31 0.3× 25 0.3× 60 914
Ming Jiang China 10 279 0.9× 105 0.6× 96 0.9× 28 0.3× 56 0.7× 37 885
Xavier Poiré Belgium 17 401 1.4× 148 0.8× 197 1.9× 15 0.2× 54 0.7× 69 971
Woo Sung Min South Korea 16 241 0.8× 125 0.7× 123 1.2× 24 0.3× 70 0.9× 47 696
Tamio Fujita Japan 11 112 0.4× 85 0.5× 95 0.9× 32 0.3× 36 0.4× 41 376
TA Fleisher United States 8 353 1.2× 115 0.6× 93 0.9× 18 0.2× 71 0.9× 13 849
Luigino Boschiero Italy 16 278 0.9× 192 1.0× 70 0.7× 10 0.1× 40 0.5× 36 746

Countries citing papers authored by Stanislav Kormunda

Since Specialization
Citations

This map shows the geographic impact of Stanislav Kormunda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stanislav Kormunda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stanislav Kormunda more than expected).

Fields of papers citing papers by Stanislav Kormunda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stanislav Kormunda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stanislav Kormunda. The network helps show where Stanislav Kormunda may publish in the future.

Co-authorship network of co-authors of Stanislav Kormunda

This figure shows the co-authorship network connecting the top 25 collaborators of Stanislav Kormunda. A scholar is included among the top collaborators of Stanislav Kormunda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stanislav Kormunda. Stanislav Kormunda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Reischig, Tomáš, Martin Kacer, Kristýna Pivovarčíková, et al.. (2023). A Randomized Trial of Valganciclovir Prophylaxis Versus Preemptive Therapy in Kidney Transplant Recipients. Journal of the American Society of Nephrology. 34(5). 920–934. 12 indexed citations
2.
Reischig, Tomáš, Martin Kacer, Lukáš Kielberger, et al.. (2021). Insufficient response to mRNA SARS-CoV-2 vaccine and high incidence of severe COVID-19 in kidney transplant recipients during pandemic. American Journal of Transplantation. 22(3). 801–812. 33 indexed citations
3.
Reischig, Tomáš, Martin Kacer, Ondřej Hes, et al.. (2019). Cytomegalovirus prevention strategies and the risk of BK polyomavirus viremia and nephropathy. American Journal of Transplantation. 19(9). 2457–2467. 26 indexed citations
4.
Reischig, Tomáš, Martin Kacer, Ondřej Hes, et al.. (2019). Viral load and duration of BK polyomavirus viraemia determine renal graft fibrosis progression: histologic evaluation of late protocol biopsies. Nephrology Dialysis Transplantation. 34(11). 1970–1978. 16 indexed citations
5.
Reischig, Tomáš, Martin Kacer, Petra Hrubá, et al.. (2018). Less renal allograft fibrosis with valganciclovir prophylaxis for cytomegalovirus compared to high-dose valacyclovir: a parallel group, open-label, randomized controlled trial. BMC Infectious Diseases. 18(1). 573–573. 17 indexed citations
6.
Kleiblová, Petra, et al.. (2012). Contribution of the β-ureidopropionase (UPB1) gene alterations to the development of fluoropyrimidine-related toxicity. Pharmacological Reports. 64(5). 1234–1242. 17 indexed citations
7.
Liška, Václav, L Holubec, Jindra Vrzalová, et al.. (2012). Matrix metalloproteinases and their inhibitors in correlation to proliferative and classical tumour markers during surgical therapy of colorectal liver metastases. Bratislavské lekárske listy/Bratislava medical journal. 113(2). 108–113. 2 indexed citations
8.
Kleibl, Zdeněk, Ondřej Havránek, Stanislav Kormunda, et al.. (2010). The AIB1 gene polyglutamine repeat length polymorphism and the risk of breast cancer development. Journal of Cancer Research and Clinical Oncology. 137(2). 331–338. 4 indexed citations
9.
Zikán, Michal, Zdeněk Kleibl, Markéta Janatová, et al.. (2010). Population-based study of BRCA1/2 mutations: Family history based criteria identify minority of mutation carriers. Neoplasma. 57(3). 280–285. 8 indexed citations
10.
11.
12.
Kleiblová, Petra, et al.. (2009). Contribution of dihydropyrimidinase gene alterations to the development of serious toxicity in fluoropyrimidine-treated cancer patients. Cancer Chemotherapy and Pharmacology. 65(4). 661–669. 21 indexed citations
13.
Fínek, Jindřich, et al.. (2009). A phase II trial of oral vinorelbine and capecitabine in anthracycline pretreated patients with metastatic breast cancer.. PubMed. 29(2). 667–70. 37 indexed citations
14.
Pešta, Martin, Václav Liška, Vladislav Třeška, et al.. (2007). Clinical Relevance of the Expression of mRNA of MMP-7, MMP-9, TIMP-1, TIMP-2 and CEA Tissue Samples from Colorectal Liver Metastases. Tumor Biology. 28(5). 247–252. 26 indexed citations
15.
Liška, Václav, et al.. (2007). Recurrence of colorectal liver metastases after surgical treatment: multifactorial study.. PubMed. 54(78). 1741–4. 1 indexed citations
16.
Holubec, L, Ondřej Topolčan, Martin Pešta, et al.. (2007). Expression of mRNA MMP-7 and mRNA TIMP-1 in non-small cell lung cancer.. PubMed. 27(4C). 2953–6. 12 indexed citations
17.
Topolčan, Ondřej, et al.. (2007). Changes of serum thymidine kinase in children with acute leukemia.. PubMed. 27(4A). 1925–8. 11 indexed citations
18.
Reischig, Tomáš, Pavel Jindra, Miroslava Švecová, et al.. (2006). The impact of cytomegalovirus disease and asymptomatic infection on acute renal allograft rejection. Journal of Clinical Virology. 36(2). 146–151. 70 indexed citations
19.
Pešta, Martin, L Holubec, Ondřej Topolčan, et al.. (2005). Quantitative estimation of matrix metalloproteinases 2 and 7 (MMP-2, MMP-7) and tissue inhibitors of matrix metalloproteinases 1 and 2 (TIMP-1, TIMP-2) in colorectal carcinoma tissue samples.. PubMed. 25(5). 3387–91. 37 indexed citations
20.
Holubec, L, Ondřej Topolčan, Jindřich Fínek, et al.. (2005). Markers of cellular adhesion in diagnosis and therapy control of colorectal carcinoma.. PubMed. 25(3A). 1597–601. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Roni Tamari Breakdown of academic impact, for papers by Ken Ishiyama Breakdown of academic impact, for papers by Masatoshi Sakurai Breakdown of academic impact, for papers by Maija Itälä‐Remes Breakdown of academic impact, for papers by Ming Jiang Breakdown of academic impact, for papers by Xavier Poiré Breakdown of academic impact, for papers by Woo Sung Min Breakdown of academic impact, for papers by Tamio Fujita Breakdown of academic impact, for papers by TA Fleisher Breakdown of academic impact, for papers by Luigino Boschiero
Rankless by CCL
2026